Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Assessment of two treatment schedules for OSI-7836 in cancer patients

Nov. 27, 2003

Preliminary results for motexafin gadolinium combined with doxorubicin in solid tumors

Nov. 27, 2003

Good safety profile found for LE-SN-38 in advanced cancer patients

Nov. 27, 2003

MLN-2704 potentially effective against bone metastases in prostate cancer

Nov. 27, 2003

Low systemic toxicity reported for NLCQ-1 in rats

Nov. 27, 2003

ImClone seeks approval for Erbitux in Canada

Nov. 26, 2003

Urethane derivative of pladienolide B with enhanced antitumor activity

Nov. 26, 2003

European CPMP hands down positive opinion for Faslodex

Nov. 26, 2003

Four related series of Akt kinase inhibitors presented by Merck

Nov. 26, 2003

Mechanism of action of the Hsp90 inhibitor CCT-018159 discussed in Boston

Nov. 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...